1 / 8CLSA on Sun TV: The brokerage maintains a 'buy' call on the stock with a target at Rs 645 per share. It said that Sun TV is ramping up its movie business and raised the FY21-23 profit estimate by 4-8 percent.
2 / 8Macquarie on Sun TV: The brokerage maintains an 'outperform' call on the stock with a target at Rs 612 per share. Sun TV’s current valuations are still undemanding, Macquarie added.
3 / 8UBS on Sun TV: The brokerage is 'neutral' on the stock with a target at Rs 505 per share. Sun TV’s advertising recovery is weaker than expected, UBS said, adding that Sun NXT will aid subscription revenue going ahead.
4 / 8CLSA on Torrent Pharma: The brokerage has a 'buy' call on the stock with a target at Rs 3,560 per share. The company's India positioning is strong, CLSA said after a good Q3 show.
5 / 8Citi on Torrent Pharma: The brokerage has a 'buy' call on the stock with a target at Rs 3,100 per share. The firm sees a strong margin, it added.
6 / 8Credit Suisse on Torrent Pharma: The brokerage maintains an 'underperform' call on the stock with a target at Rs 2,280 per share. Q3 an in-line quarter for Torrent Pharma, CS said, reinforcing view of high margin expectations.
7 / 8Credit Suisse on Godrej Consumer: The brokerage maintains an 'outperform' call on the stock with a target at Rs 875 per share. It is positive on the firm's medium-term push to become a broad-based household and personal care company.
8 / 8Nomura on PNC Infra: The brokerage maintains a 'buy' call on the stock and raised the target to Rs 364 per share from Rs 255 earlier. Large order book, low leverage-positive catalysts for PNC Infra, it added.
